Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Khan, , Russell,
DOB: 29-AUG-1980 (Age: 45)
Gender: male
Address:
1 Holly well
B9 Allantown (United Kingdom)
ID: 7982-255119-2 (ECI)
Report
Date: 16-DEC-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Birmingham Children's Hospital
B4 6 Birmingham (United Kingdom)
Specimen
Collected: 16-DEC-2018

Chemistry

Test 16-DEC-2018 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 185.5 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 141.5 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 94.7 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 62.5 H 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Lipid profile is within or close to normal limits: total cholesterol, triglycerides, and LDL are in the desirable range. HDL is slightly elevated, which is generally considered protective. No significant laboratory abnormalities detected; results are favorable from a cardiovascular risk perspective. Recommend continued healthy lifestyle.